Humana Foundation Allots $7.6M to Social Determinants of Health

Samantha McGrail | January 31, 2020

The Humana Foundation announced it is investing $7.6 million in eight communities across the southeastern United States to address social determinants of health (SDOH), according to a recent press release. The most recent investment is part of the philanthropic organization’s Strategic Community Investment program, which aims to address some of the most common social determinants of health, including post-secondary attainment and sustaining employment, social connectedness, financial asset security, and food security. As part of its ongoing program, the foundation recently engaged in two new investments in New Orleans totaling $1 million. The investments will address financial asset security, post-secondary attainment and sustaining employment and food security. Additionally, the Humana Foundation will continue its existing investments with ten organizations in seven other communities, including Baton Rouge, Louisiana.

Spotlight

Every company in the hospitality industry wants their guests to feel at home on their prope even more comfo able than they are in their living room. In today’s connected world, businesses that adopt next-gen technology have an edge over those satisfied with the status quo.

Spotlight

Every company in the hospitality industry wants their guests to feel at home on their prope even more comfo able than they are in their living room. In today’s connected world, businesses that adopt next-gen technology have an edge over those satisfied with the status quo.

Related News

DIGITAL HEALTHCARE, MEDICAL DEVICES

IKS Health makes strategic investment in Abridge to launch a partnership that enables the creation of accurate and trusted generative AI models

Businesswire | May 19, 2023

IKS Health, a healthcare Provider Enablement Platform, and Abridge, a Generative AI for Healthcare Platform, announced an expansive partnership to build and deploy AI-based technology that can reduce the administrative burden that is currently driving provider burnout and staffing shortages. Over the coming months, IKS will leverage Abridge’s generative AI to realize efficiencies in their clinical documentation services. In turn, IKS will accelerate the development of Abridge’s core AI technologies by contributing feedback from their large workforce of medical professionals. This alignment between both parties, empowered by IKS’ strategic investment in Abridge, advances both company’s respective missions to scale their impact across the healthcare system at a critical time when costs and clinician burnout are at unprecedented levels. Both teams are aligned in their journey to eliminate administrative work and are driven by the rising rates of burnout among clinicians that is leading many to exit the healthcare workforce. According to a paper recently published in the Journal of General Internal Medicine, physicians would require more than 27 hours a day to deliver all of the clinical and administrative work asked of them. Clinical documentation burden has been amongst the biggest drivers of provider burnout, which in turn has further exacerbated the demand-supply gap in care delivery. IKS is a healthcare enablement platform focused on assisting US-based healthcare organizations deliver better, safer and cost-effective care through a strategic blend of technology and domain expertise.. In this case, Abridge has developed a generative AI solution for automating clinical note drafts and associated structured data in the formats preferred by clinicians. "The most important relationship in healthcare is between the patient and the provider, and this is also the most compromised one today due to the mounting administrative burden on providers. Our goal is to assist clinicians by taking away and assisting them with the administrative chores and enable them to focus on their core value of building trusted relationships with their patients in order to drive better clinical outcomes,” said Sachin K. Gupta, founder & CEO of IKS. “Our partnership with Abridge will transform how generative AI will be leveraged in a pragmatic, provider-ready solution that enables them to deliver better, safer and more efficient care at scale." According to Zack Lipton, Abridge’s Chief Scientific Officer, “While the possibilities for generative AI to revolutionize health care are boundless, this engine is fueled by feedback loops, and the most important data in healthcare doesn’t live on the open web.” Shiv Rao, CEO of Abridge said, “Abridge has developed a first-of-its-kind generative AI solution for healthcare. This partnership will improve all of our core technologies and also unlock opportunities to improve downstream care delivery workflows in ways not previously imagined.” IKS and Abridge are committed to Responsible AI principles and, most critically, the highest healthcare industry standards for data privacy and security. Both parties are accountable to HIPAA-compliant data storage and processing protocols for all data captured and shared, and IKS meets HITRUST certification requirements. The machine learning models leveraged by the joint solution are only trained on de-identified data, and all data is encrypted at-rest and in-transit using FIPS 140-2 validated encryption. About IKS Health IKS Health’s healthcare Provider Enablement Platform delivers data-driven value and expertise across the care journey that enables provider enterprises to achieve clinical, financial and operational excellence at scale. Supporting health care providers through every function of the patient visit, IKS Health is a partner for provider enterprises looking to effectively scale, improve quality and achieve cost savings through integrated technology and forward-thinking solutions. Founded in 2006, the 6,500+ member strong workforce at IKS Health as at March 2023 includes over 1,300 physicians, over 300 technology experts and supporting large health systems across the United States.

Read More

AI, DIGITAL HEALTHCARE

Caregility Unveils Multiple AI-Enhanced Hybrid Care Solutions that Harness the Power of Caregility Cloud™ Telehealth Platform

Businesswire | April 19, 2023

Caregility, an enterprise telehealth leader dedicated to connecting care for patients and clinicians everywhere, today announced a new portfolio of AI-enhanced hybrid care solutions built on Caregility Cloud™, its Best in KLAS virtual care platform (non-EMR). The enhancements reduce technology investment risks for hospitals and health systems by offering the flexibility to choose those health AI applications that are the best fit for their environment and needs without creating more IT silos that could hamper workflow and congest networks. Interest in hybrid care models that blend in-person care with virtual encounters has increased significantly as health systems look to optimize patient care delivery amid workforce shortages. Caregility Cloud™ is a robust telehealth foundation that helps modernize care delivery with advanced video and audio streaming technologies. Transformative clinical programs built on the platform include virtual nursing, tele-ICU, continuous patient observation, and virtual visits. The AI enhancements announced today unlock even more value for overburdened caregivers and administrative teams struggling to keep up with rising costs and increased demand. A computer vision application analyzes live video streams of patients and their environment to detect movement and changes that could lead to adverse events such as falls or self-harm. A contactless monitoring system continuously captures patient vital signs, detecting variations in heart rate, breathing patterns, and movement that could be indicative of physiological events like awakening from sleep or an induced coma. An ambient clinical intelligence algorithm generates documentation from live clinician and patient conversations for the patient’s electronic health record. “Integrating artificial intelligence technologies with our leading virtual care platform advances care delivery and empowers the clinicians we serve to focus on patient care,” states Mike Brandofino, President and COO at Caregility. “AI development in healthcare is in the beginning stages. Our customers are asking us for options that they can implement now but won’t box them into an investment that might quickly become obsolete. By harnessing the power of Caregility Cloud™ as the platform of choice, we provide the resilient virtual care infrastructure and endpoints while our business partners focus on AI advancement.” “Combining virtual care solutions and AI technology yields tremendous potential to enhance and improve a variety of clinical workflows in acute care settings,” said Pete McLain, Chief Strategy Officer at Caregility. “Artificial intelligence has the potential to enhance and augment – not replace – care teams, helping them save time, capture more meaningful patient data, and support clinical decisions and interventions that lead to better care and improved patient outcomes.” The Caregility Cloud™ Ecosystem is a growing network of Caregility business partners brought together for better healthcare. The new AI innovators joining the ecosystem include Abridge, Ouva, and Xandar Kardian, who are committed to integrating their transformative AI-enhanced hybrid care solutions with the Best in KLAS virtual care platform. Abridge, a leader in the clinical adaptation of generative AI, introduces ambient clinical intelligence for Caregility Cloud™, capturing relevant medical documentation from clinical conversations with patients in near real-time. Ouva, a pioneer in the clinical application of computer vision, brings AI-powered continuous patient and patient room observation to Caregility Cloud™ adopters, tracking patient and visitor movement to alert care teams to potential patient safety concerns such as falls, elopement, or self-harm. The Ouva solution also helps optimize workforce efficiency, with bedside shift planning and bed turnover processes. Xandar Kardian, an innovator in radar-based contactless patient monitoring, adds continuous vital sign and motion capture to Caregility Cloud™, delivering real-time data on patients’ resting heart rate, respiratory rate, and motion patterns to remote clinical teams to assess trends and meaningful changes in patient conditions. The Caregility Cloud™ virtual care platform also leverages operational AI to remotely monitor telehealth endpoint systems and initiate self-healing commands if equipment is not performing properly, enabling health systems to manage large telehealth system deployments at scale and across multiple sites. About Caregility Caregility Corporation is dedicated to connecting patients and clinicians everywhere with its Caregility Cloud™ virtual care platform. Awarded the Best in KLAS Virtual Care Platform (non-EMR) in 2021, 2022, and 2023, Caregility Cloud™ powers a purpose-built ecosystem of enterprise telehealth solutions across the care continuum. Caregility provides secure, reliable, and HIPAA-compliant audio and video communication designed for any device and clinical workflow, in both acute and ambulatory settings. Today Caregility supports more than 1,000 hospitals across over 75 health systems with over six million virtual care sessions hosted annually.

Read More

FUTURE OF HEALTHCARE, HEALTHCARE ANALYTICS

REVIV Partners with Randox Health

Businesswire | April 24, 2023

SVP for Retail Health, Joanne Lomas-Braithwaite, is pleased to announce the partnership between REVIV Global and Randox Health. Randox Health was established in 1982 and is the largest healthcare diagnostics company in the UK and Ireland. For over 40 years Randox have been focusing on the provision of timely and accurate proteomic and genomic testing to identify risk to health and promote preventative healthcare. With personalised, private health packages designed to provide real-time insights on current health and future health risks, Randox Health’s nationwide network of clinics offer unique access to health data to help monitor and improve your health. The exciting partnership is a first for Randox who will be offering REVIV’s therapies in their clinics alongside their own diagnostic testing. REVIV’s full menu of IV drip therapies and IM booster shots will be available for their customers to support their journey to optimize their wellness. On REVIV partnering with Randox, David Ferguson, Chief Operating Officer, says: “Over the past few years, we've seen a dramatic change in people's behaviours as they seek to understand their health and wellbeing better. At Randox Health, we provide a range of specialised health packages that enable you to take control of your health. “Our innovative diagnostic technologies can deliver hundreds of results to give you a comprehensive overview of your health and help detect the earliest signs of illness. Collaborating with REVIV is a natural next step, combining our world-class diagnostic services with REVIV signature IV therapies to help our customers protect their current and future health.” Joanne Lomas-Braithwaite, SVP Retail Health, says: “We are thrilled about the future of our multi-unit Express partnership with Randox, a prominent figure in healthcare diagnostic testing. Through our new digital SaaS solution, Express, this collaboration will extend our goal of providing personalised nutrition experiences to our customers, with an increased accessibility to our customers through Randox's extensive clinic network.” About REVIV REVIV is a global leader in doctor-led preventative health services. Education sits at the very core of REVIV. We continually strive to raise awareness on the importance of preventative health and provide the public with the resources to be able to take control of their health. We were founded in 2010 by four doctors who experienced long, emotionally challenging hours in the emergency room. These experiences led them to the decision that the public needed to become aware of the importance of preventative health in protecting against illness & disease.

Read More